Get Permission Gahoi, Usha, Sharma, Nongphud, Mishra, and Singh: Immunopathological study of crescentic glomerulonephritis with special reference to antineutrophilic cytoplasmic antibodies


Introduction

Crescentic Glomerulonephritis (CGN) is characterized by the presence of extensive glomerular crescents in more than 50% of the glomeruli. It presents with rapidly progressive Glomerulonephritis (RPGN). It could be primary and secondary. CGN is classified into 5 types (Parmar 2017).1

Type I – It shows linear deposits of immunoglobulins IgG along the glomerular basement membrane (Anti GBM disease).

Type II – It shows granular deposition of immunoglobulins and complement (Immune complex mediated disease).

Type III – Few or no immune deposit in glomeruli (Pauci-immune). It is antineutrophilic cytoplasmic antibody (ANCA) associated with small vessel vasculitis.

Type IV – Combination of Type I and Type III

Type V – ANCA, immune complex and anti GBM Ab negative (pauci-immune renal vasculitis).

Pauci-immune crescentic glomerulonephritis (PICGN) accounts for 80% of the cases of rapidly progressive GN.2, 3, 4 Majority of the cases of PICGN are due to primary systemic small vessel vasculitis e.g., GPA, MPA or renal limited vasculitis (RLV).5 ANCA is present in 80% – 90% of the patients with PICGN. Patients with both ANCA associated GN usually present with rapidly progressive GN with haematuria, proteinuria and elevated serum creatinine.6 Histopathologically, these patients have necrotising GN and extensive crescents.7 A small subset of patients have subacute disease and on renal biopsy have glomerular sclerosis either alone or accompanied by focal active disease with necrosis and crescents.8 In most of the patients, PICGN is a component of systemic small vessel vasculitis.

In 2010 International Vasculitis working study group9 have classified ANCA mediated CGN into 4 types which predict the survival rate of patients. This includes

  1. Focal: > 50% normal glomeruli are present.

  2. Crescentic: > 50% glomeruli with cellular crescents.

  3. Mixed: < 50% normal glomeruli, <50% crescentic, <50% globally sclerotic glomeruli.

  4. Sclerotic: > 50% globally sclerotic glomeruli.

Crescentic and mixed group have the worst prognosis when <25% of the normal glomeruli are present.10

CGN is very commonly seen in our country but very few studies are available in India. The aim of study is to find out various subtypes of CGN, and prevalence of ANCA and its subtypes in PICGN.

Materials and Methods

The total 50 cases of CGN were studied between the period of February 2016 to July 2017. Cases were taken from the Department of Nephrology & Dermatology. A detail clinical history was taken and 5ml blood in plain vial was taken after consent of the patients for immunological tests like ANCA, ANA, ds DNA Ab and anti GBM Ab.

Only kidney biopsy proved cases of CGN were taken. Histopatholoically it was classified first according to Parmar 2017.1 classification. PICGN was further classified into 4 groups depending upon International classification proposed by Berden et al 2010.9

Kidney biopsy were preserved in 10% buffered formalin. Paraffin blocks were prepared and sections were stained with Haematoxylin and Eosin (H&E), Periodic Acid Schiff (PAS) and Acid Fuchsin Orange G (AFOG) stains as described by Zollinger and Mihtash 1978.11

PR3 and MPO ANCA were done by ELISA kit of Euro diagnostica, Sweden supplied by MIS OSB agencies, Geeta Colony. For PR3, ELISA value more than 9.6 U/mL was considered as positive. For MPO ANCA, value above 12.7 U/mL was taken as positive. For anti GBM, value above 18 U/mL; for ANA, value above 1.2; for anti ds DNA, value above 46 IU/mL.

In CGN, blood vessels were destroyed & not visible due to severe mononuclear cell infiltrate. Hence, CD34 staining was done by immuneperoxidase method to see the endothelial cells of the blood vessels. Monoclonal Ab against CD34 and secondary antibody including substrate kit was purchased from Biogenex Emergo Europe, Molenstraat 15, NL-2513BH, Hague, Netherland supplied by MIS Biogenes.

Result

CGN included total of 50 cases. Sex wise distribution showed that males were slightly more affected (26 cases - 52%) than females (24 cases - 48%); although statistically it was non-significant.

Distribution of CGN revealed that 52% patients were in the 3rd and 4th decades of their life, 14% patients were children below 16 years of age and 34% were above 40 years. Age varied from 13 – 86 years. Age wise difference was significant (x2 = 21.52, P<.001). Mean age: 38.4 ± 16.9 years.

Subtypes of CGN revealed that Type III (PICGN) was more commonly found (60% cases) followed by Type IV CGN and Type V (12% each), Type I and Type II formed 8% each so as a whole 72% of CGN were ANCA positive and 20% were anti GBM positive.

All 36 ANCA positive CGN cases were further classified. It was found that maximum cases were of crescentic type (47.2%) followed by sclerotic type (25%), focal (16.7%) and mixed (11.1%).

All 50 CGN cases were further examined and subjected to various tests to know secondary causes. Evidence of SLE was found in 14 cases (28%). Out of these 14 cases, 64.28% were females and 35.71% males. Anti ds DNA Ab was positive in only 57.14% and anti Sm Ab was seen in 5 cases (35.71%). All patients fulfilled the criteria of SLE. MPO ANCA was positive in 50%, PR3 in 28.57% & anti GBM + anti MPO in 7.14% in SLE.

Out of 50 CGN cases, only 36 cases (72%) were ANCA positive. Out of these MPO ANCA was more common in both type III and IV CGN forming 53.33% and 66.66%, whereas PR3 ANCA was less common in both varieties (40% type III & 33.33% type IV). Two of these cases (6.6%) were dual ANCA positive for PR3 and MPO.

Most common histopathological findings in glomerulus were fibrocellular and fibrous crescents (Figure 1) found in 80% followed by hyalinization and sclerosis. In 34% cases, there were also cellular crescents. Bowman’s capsule necrosis was seen in 66.7% cases of Type IV and 60% cases of Type III and 33.3% cases of Type V CGN.

Granuloma in glomeruli were seen mostly in Type IV CGN and 25% cases of Type III and Type II CGN (Figure 2). RBC casts were seen mostly in Type IV CGN followed by Type V and Type I (80% each). Interstitium showed moderate to heavy mononuclear cell (MNC) infiltration in more than 75% of all types of CGN. Lymphoid follicles infiltration in interstitium is seen mostly in Type IV (33.3%) and Type I (25%) & Type V (16.7%). Non caseating epithelial granuloma was found in 25% cases of Type III, I and II and 16.7% cases of Type IV and V (Table 1).

In CGN, small blood vessels vasculitis was more common (60%) followed by fibromuscular hyperplasia (56%), hyaline thickening (44%), medium sized vessel vasculitis (22%), thrombosis (22%) and fibrinoid necrosis of blood vessels (16%). Small vessel vasculitis included glomerular and peritubular capillaritis. All peritubular vasculitis was not obvious because of inflammatory cells, only after CD34 staining destroyed capillaries were identified. In SLE, venulitis was more common. In Type I CGN, common findings were hyaline thickening (75%), fibromuscular hyperplasia (50%), small vessel vasculitis (50%), thrombosis in blood vessels, fibrinoid necrosis and medium sized blood vessel vasculitis (25%). Among Type II CGN only one case had vasculitis (25%) of small blood vessel. (Table 2) (Figure 3, Figure 4, Figure 5)

In Type III CGN small vessel vasculitis was more common (63.33%) whereas medium sized blood vessel vasculitis was seen in 20% cases and thrombus was found in 26.7% cases. As a whole vasculitis was seen in only 83.3%. In 2 cases (6.66%) epithelioid granuloma was found in blood vessel also. In Type IV, all cases showed vasculitis in which 50% showed small vessel and 50% showed medium sized blood vessel vasculitis. In type V small vessel vasculitis was present in 83.33%. One case of eosinophilic granulomatous polyangitis was a 40 years old female who manifested with acute renal failure, allergic rhinitis, proteinuria, haematuria, anaemia, leucocytosis and eosinophilia of 28%. Her MPO ANCA was positive and blood urea and serum creatinine were raised. Histopathology of kidney showed cellular crescents in more than 80% glomeruli, tubular necrosis, mononuclear cell infiltrate with many neutrophils and eosinophils in the interstitium. There was small vessel vasculitis with plenty of eosinophils.

Out of 41 cases, 8 cases (19.5%) of GPA were identified. Age varied from 17 years to 60 years (52 M, 33 M, 17 F, 55 M, 48 M, 32 F, 60 M, 36 M). Out of 8 cases, 6 (75%) were males and 2 (25%) were females.

Fever was present in 50% cases, rash and arthritis in 25% (2 cases). One case (12.5%) had otitis media with abscess in middle ear. Pulmonary symptoms were found in only 50% of the cases which comprised of breathlessness, cough, hemoptysis, nasal bleeding. All patients had swelling of face and feet, raised blood urea and serum creatinine. (Table 3)

All GPA patients had small vessel vasculitis (SVV) and granuloma (interstitium: 4 cases – 50%; glomeruli: 2 cases – 25%; blood vessel: 2 cases – 25%). Before CD34 staining, SVV was seen in 3 cases, but after staining, it was found in all cases.

Figure 1

Shows focal cellular crescent at 6 O’clock position whereas in other part it is fibrocellular. (H&E X 400)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/395ea978-8687-4417-bcb2-a4060bddf545image1.png

Figure 2

Showing small non caseating granuloma in periglomerular area of wegener’s granulomatosis. (H&E X400)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/395ea978-8687-4417-bcb2-a4060bddf545image2.png

Figure 3

Showing severe vasculitis of peritubular capillaries in MPA with mononuclear cell infiltration on the left side but medium sized blood vessel on right side does not show vasculitis (H&E X 400)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/395ea978-8687-4417-bcb2-a4060bddf545image3.png

Figure 4

CD34 staining of venulitis showing destruction of endothelial cells (loss of CD34 staining) & heavy MNC infiltration. (IP staining with CD34 X400)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/395ea978-8687-4417-bcb2-a4060bddf545image4.png

Figure 5

Showing fibrinoid necrosis of vessel wall (red colour), vasculitis & hyaline thrombi in lumina. (AFOG X 400)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/395ea978-8687-4417-bcb2-a4060bddf545image5.png

Table 1

Showing glomerular, tubular and interstitial pathology into various types of CGN

Histological changes Type I N=4 No. (%) Type II N=4 No. (%) Type III N=30 No. (%) Type IV N=6 No. (%) Type V N=6 No. (%) Total N=50 No. (%)
Glomerular, hyalinization and sclerosis 02 (50) 03 (75) 18 (60) 04 (66.7) 05 (83.3) 32 (64)
Fibrous and fibrocellular crescents 03 (75) 03 (75) 22 (73.33) 04 6 (66.7) 06 (100) 40 (80)
Necrosis of Bowman’s capsule -- -- 18 (60.9) 04 (66.7) 02 (33.3) 24 (60)
Granuloma in glomerulus -- 1 (25) 8 (26.6) 02 (33.3) -- --
Tubular atrophy 03 (75) 2 (50) 20 (66.7) 03 (50) 06 (100) 33 (66)
Thyroidization of tubules 01 (25) 1 (25) 10 (33.33) 01 (16.7) 03 (50) 16 (32)
RBC casts 02 (50) 04 (100) 11 (36.7) 04 (66.7) 03 (50) 21 (42)
Moderate to heavy mononuclear cell infiltration in interstitium 01 (25) -- 28 (93.3) 05 (83.3) 06 (100) 46 (92)
Lymphoid follicles in interstitium 01 (25) 1 (25) 04 (13.3) 02 (33.3) 01 (16.7) 8 (16.7)
Granuloma in interstitium 02 (50) -- 8 (26.7) 01 (16.7) 01 (16.7) 11 (22)
Plenty of neutrophils in interstitium -- -- 08 (26.7) 08 (26.7) 2 (33.33) 14 (28)

[i] (Figures in parenthesis suggest percentage)

Table 2

Ishowing histopathological findings of blood vessels in various types of CGN

Vascular changes Type1 CGN N=5 (%) Type2 CGN N=4 (%) Type 3 CGN N=30 (%) Type 4 CGN N=6 (%) Type 5 CGN N=6 (%) Total N=50 (%)
Hyaline thickening 03 (75) 02 (50) 13 (43.3) 02 (33.3) (66.7) 02 (33.3) 22 (44)
Fibromuscular hyperplasia 02 (50) 02 (50) 17 (56.7) 04 (66.7) 3 (50) 28 (56)
Thrombus 01 (25) -- 08 (26.7) 01 (16.7) 01 (16.7) 11 (22)
Fibrinoid necrosis 01 (25) -- 04 (10) 04 (66.7) -- 08 (16)
Arcuate interlobular arteritis 01 (25) -- 06 (20) 03 (50) 01 (16.7) 11 (22)
Vasculitis of small blood vessels 02 (50) 01 (25) 19 (63.3) 03 (50) 05 (83.3) 30 (60)
Granuloma in blood vessels -- 2 (6.66) -- -- --

Table 3

Showing clinical features of GPA

Groups Age in years Sex ANCA General Renal Respiratory problems
Patient 1 52 Male PR3 Fever with Swelling of body Proteinuria and haematuria Cough
Patient 2 33 Male MPO Fever with swelling of feet Do Haemoptysis
Patient 3 17 Female PR3 Fever, rash, arthritis and swelling of feet Do Nasal bleeding
Patient 4 55 Male PR3 Fever with swelling of body Do Chest pain
Patient 5 48 Male PR3 Rash and arthritis Do --
Patient 6 32 Female PR3 Otitis media and abscess in middle ear Do --
Patient 7 60 Male PR3 Swelling of body Do --
Patient 8 36 Male PR3 Swelling of body, fever and rash Do --

Discussion

ANCA is important cause of vasculitis. Presence of ANCA is also reported in infections and malignancy such as myelodysplastic syndrome, Hodgkin lymphoma, SLE and systemic sclerosis.12 This is also an important cause of pauci-immune CGN. CGN is classified into 5 Types. Among them, one of the common type is Type III which is characterized by the absence of immune complexes hence known as Pauci-immune CGN. Majority of Type III CGN are ANCA positive.1 We studied 50 cases of CGN. Most common CGN was Type III which formed 60% of the cases while Type IV and Type V were seen in 12% cases each followed by Type I and Type II which formed 8% cases each. As a whole in more than 72% of CGN, ANCA was positive. There are variable reports regarding frequency of CGN, Gupta et al 201113 found ANCA negative pauci-immune CGN in 39.1% followed by ANCA positive pauci-immune (32.6%) and Type II CGN (28.3%). Like us Choudhury et al 201414 also found predominance of type III CGN (32.4%) followed by type II (23.5%), type V (18%), type I (14.5%) and type IV (11.7%) CGN.

Some studies indicate that type V CGN is very rare and comprises less than 5%.15, 16 While in our study it was seen in 12% cases.

In CGN, we found slight male predominance (52%) over females (48%) with male to female ratio of 1.1:1. Contrary to our study other workers found slight female predominance. Gupta et al 13 found male to female ratio of 1:1.1 while Choudhury et al14 found it to be 1:1.8. In our study, age range was from 13 - 86 years while mean age was 38.4 ± 16.9 years. More or less similar to our study mean age was 32.2 ± 16.1 years in series of Choudhury et al 2014.14 Age range in their series was 12 - 72 years and maximum cases (76.5%) were between 21 - 59 years, 11.7% cases were below 20 years and 11.7% cases were above 60 years. In our series 14% patients were below 16 years and 10% patients were above 61 years.

Contrary to this, Gupta et al 201113 found that in CGN age ranges from 4.5 to 72 years with mean age of 26.6 ± 17.1 years. In their series, 26.08% patients were below 14 years of age.

In present study, MPO positivity was seen in 50% CGN followed by PR3 positivity (44.4%). In 5.6% cases, both MPO and PR3 were positive. In series of Choudhury 14 et al, MPO ANCA was more common (81.8%) followed by PR3 ANCA and combined MPO and PR3 ANCA (9.1%) each.

We classified all 36 ANCA positive cases and found crescentic to be more common (47.2%). Similar to us, Naidu et al 201417 also reported crescentic to be more common while some studies (Ellis et al 201318 and Togashi et al 201619 found mixed variety to be more common.

Out of 50 CGN cases, vasculitis was seen in 41 (82%) cases. Commonest vasculitis was MPA (78.04%) followed by GPA in 19.5% and EGPA (2.44%). ANCA vasculitis with lupus nephritis was seen in 31.7% cases, immune complex vasculitis in 9.8% and ANCA negative pauci-immune vasculitis in 2.4% cases.

Naidu et al 201317 also reported higher incidence of GPA (56.6%) followed by MPA (40.8%). Vasculitis of interlobular arteries was seen in 50% of the cases of Type IV, 20% cases of Type III and 25% of the cases of Type II and 16.7% cases of Type V. Vizjak et al 20036 found active vasculitis in 23% of both MPO and PR3 ANCA positive cases. This difference may be due to the fact that they have noticed only medium sized blood vessel vasculitis. In our case also medium sized blood vessel vasculitis was present in 22% cases while peritubular capillaritis was missed in H&E stain but was visualized after CD34 staining.

One case was diagnosed as EGPA in a 40 years old female. This case was MPO positive. Similar to our case, Karamoto et al 201620 also reported a case of EGPA in a 64 years old female patient who had allergic rhinitis with sinusitis, breathlessness, pleural effusion, leucocytosis, eosinophilia, proteinuria, haematuria, raised blood urea and serum creatinine. Her case was also MPO positive and her renal biopsy revealed granuloma in the interstitium with MNC infiltration and eosinophilia.

Sinico et al 200621 reported that renal involvement is uncommon and is seen only 25% cases of EGPA. In CGN, we found evidence of GPA in 8 cases with mean age of 41 years with male predominance. Seven cases (87.5%) were PR3 positive and only one case (12.5%) was MPO positive. Pulmonary manifestations were seen in only 4 cases while nasal bleed was seen only in one case. Granuloma was present in all cases in which 50% cases were found in interstitium and 25% cases in glomeruli and rest 25% cases had it in blood vessels. Similar to our study, earlier work done in 267 cases of GPA with renal involvement22 also found mean age of 46 years with male predominance but in their study lung involvement was seen in 60.3% cases.

Aasarod et al 200122 studied 94 cases of GPA and found median age of 54 years with male predominance. About 75.5% cases were PR3 positive and 7.4% cases were MPO positive which is very close to our observation.

Conclusion

Our study concludes that CGN including SLE are the most important diseases where ANCA positive SVV is seen. Hence, our study suggests that in all cases of SLE & CGN, ANCA should be done so that aggressive immunosuppressive therapy can be given.

Source of Funding

UGC advanced Immuno-diagnostic training and research centre.

Conflict of Interests

None.

Acknowledgements

We are thankful to our technical staff, Mr. Ranjan Singh Rana, Mr. Saroj Kumar Mukherjee and Mr. Ram Ujagir Singh for their technical support.

References

1 

M S Parmar S S Bhimji Glomerulonephritis, Crescentic. Bookshelf2017

2 

R J Falk S Hogan T S Carey J C Jennette Clinical course of antineutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative NetworkAnn Intern Med199011365663

3 

Barry A. Cohen William F. Clark Pauci-immune renal vasculitis: Natural history, prognostic factors, and impact of therapyAm J Kidney Dis2000365914240272-6386Elsevier BV

4 

Anthony D Booth Mike K Almond Aine Burns Peter Ellis Gill Gaskin Guy H Neild Martin Plaisance Charles D Pusey David R.W Jayne Outcome of ANCA-associated renal vasculitis: a 5-year retrospective studyAm J Kidney Dis2003414776840272-6386Elsevier BV

5 

J. Charles Jennette Ronald J. Falk Small-Vessel VasculitisN Engl J Med1997337211512230028-4793, 1533-4406Massachusetts Medical Society

6 

Alenka Vizjak Tomaž Rott Mira Koselj-Kajtna Blaž Rozman Staša Kaplan-Pavlovčič Dušan Ferluga Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificityAm J Kidney Dis2003413539490272-6386Elsevier BV

7 

Rafeel Syed Amina Rehman Gautam Valecha Suzanne El-Sayegh Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated VasculitisBioMed Res Int20152314-6133, 2314-614110.1155/2015/402826

8 

Herbert A. Hauer Ingeborg M. Bajema Hans C. Van Houwelingen Franco Ferrario Laure-Hélène Noël Rüdiger Waldherr Renal histology in ANCA-associated vasculitis: Differences between diagnostic and serologic subgroupsKidney Int20026118090085-2538Elsevier BV

9 

Annelies E. Berden Franco Ferrario E. Christiaan Hagen David R. Jayne J. Charles Jennette Kensuke Joh Histopathologic Classification of ANCA-Associated GlomerulonephritisJ Am Soc Nephrol201021101628361046-6673, 1533-3450American Society of Nephrology (ASN)

10 

Marc Hilhorst Benjamin Wilde Peter van Breda Vriesman Pieter van Paassen Jan Willem Cohen Tervaert Estimating Renal Survival Using the ANCA-Associated GN ClassificationJ Am Soc Nephrol2013249137151046-6673, 1533-3450American Society of Nephrology (ASN)

11 

H U Zollinger M J Mihtasch Renal pathology in biopsy, Spring-verlagBerlin Heidelberg New York19781011

12 

Maria Weiner Mårten Segelmark The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA)Auto Rev20161510978821568-9972Elsevier BV

13 

AmitK Dinda Ruchika Gupta Lavleen Singh Alok Sharma Arvind Bagga SanjayK Agarwal Crescentic glomerulonephritis: A clinical and histomorphological analysis of 46 casesIndian J Pathol Microbiol20115434970377-4929Medknow

14 

Tauhidul Alam Choudhury Rana Gopal Singh Usha Shivendra Singh Takhellambam Brojen Singh Surendra Singh Rathore Clinicopathologic spectrum of crescentic glomerulonephritis: A hospital-based studySaudi J Kidney Dis Transpl2014253689961319-2442Medknow

15 

R. Angangco S. Thiru V. L. M. Esnault A. K. Short C. M. Lockwood D. B. G. Oliveira Does truly ‘idiopathic’ crescentic glomerulonephritis exist?Nephrol Dialy Transplant19949663060931-0509, 1460-2385Oxford University Press (OUP)

16 

J C Jennete Rapidlyprogressive Crescentric Glomerulonephritis Kidney Int2003633116477

17 

Godasi S. R. S. N. K. Naidu Aman Sharma Ritambra Nada Harbir Singh Kohli Vivekanand Jha Krishan Lal Gupta Histopathological classification of pauci-immune glomerulonephritis and its impact on outcomeRheumatol Int201434172170172-8172, 1437-160XSpringer Science and Business Media LLC

18 

Carla L Ellis Rebecca L Manno John P Havill Lorraine C Racusen Duvuru Geetha Validation of the new classification of pauci-immune glomerulonephritis in a United States cohort and its correlation with renal outcomeBMC Nephrol20131412101471-2369Springer Science and Business Media LLC

19 

M Togashi A Komatsuda M Nara A Omokawa S Okuyama K Sawada Validation of the 2010 histopathological classification of ANCA-associated glomerulonephritis in a Japanese single-center cohortAm J Kidney Dis201667337683

20 

Shinya Kawamoto Hideo Misawa Katsuhiro Nagahori Eosinophilic Granulomatous Polyangitis with Renal Granulomatous Angitis and Interstitial Eosinophilic Infiltration without Lung GranulomaJ Nephrol Ther2016062161-095910.4172/2161-0959.1000267

21 

Renato Alberto Sinico Lucafrancesco Di Toma Umberto Maggiore Cinzia Tosoni Paolo Bottero Ettore Sabadini Renal Involvement in Churg-Strauss SyndromeAm J Kidney Dis200647577090272-6386Elsevier BV

22 

Knut Aasarød Leif Bostad Jens Hammerstrøm Størker Jørstad Bjarne M. Iversen Renal histopathology and clinical course in 94 patients with Wegener's granulomatosisNephrol Dial Transplant2001165953600931-0509, 1460-2385Oxford University Press (OUP)



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijpo.2020.073


Article Metrics






Article Access statistics

Viewed: 1561

PDF Downloaded: 623